+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Bioconvergence Market Size, Share & Trends Analysis Report By Application (Drug Discovery, Regenerative Medicine, Bioelectronics), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2022 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • December 2022
  • Region: Global
  • Grand View Research
  • ID: 5712471
The global healthcare bioconvergence market size is expected to reach USD 215.2 billion by 2030. The market is anticipated to expand at a CAGR of 7.4% from 2022 to 2030, owing to factors including the growing geriatric population, rising stem cell technology regarding the advantages of fixing damaged cells, tissues as well as organs, and the integration of high-tech technologies and advancements such as robotics, machine learning, intelligent imaging, ergonomics (relationship between individuals and their environment), and artificial intelligence with life science. Besides healthcare, bioconvergence is finding applications in a variety of other areas as well, including agriculture, energy, food, security, climate, and others.

The COVID-19 pandemic has significantly impacted medication research, health technology, and medical technology. The incorporation of high-tech technologies such as AI and ML into the biotech research and development sector aided in understanding the pathogen and developing drugs as well as vaccines to control the spread of the virus across the globe. The amalgamation of advanced engineering, biology, physics, and computational sciences, has significantly increased the pace of drug development. According to the 2021 academic paper Frontiers in Medicine, advanced technologies such as AI have helped in efficient diagnosis, prognosis examination, epidemic prediction, and drug discovery for COVID-19.

With the rise in terms of acceptance of digital advancements, cloud-based solutions are likely to evolve in the pharmaceutical industry at an exponential pace. Regenerative medicine is evolving by merging expertise knowledge with life science, advanced engineering, robotics, computer science, and automation to provide elements for in-vivo repair.

Healthcare Bioconvergence Market Report Highlights

  • Based on application, drug discovery dominates dominated the market in terms of the revenue share of 20.0% in 2021 and is expected to witness the fastest CAGR of 8.2% from 2022 to 2030. This is attributable to the growing frequency of a broad range of ailments (such as nervous system-related disorders, and circulatory disorders), mounting medical costs, as well as the approaching patent termination of popular drugs
  • The regenerative medicine segment is likely to witness the fastest CAGR of 8.7% from 2022 to 2030 owing to its exceptional potential to treat chronic diseases such as Parkinson’s disease, Alzheimer’s disease, brain injury tissue repair, and to treat chronic diseases by target-oriented, and site-specific delivery of precise drugs
  • In 2021, Europe dominated the market with a revenue share of 29.8%, owing to the presence of leading research institutes, hospitals, and medical centers which serve a solid basis for identifying and creating innovative medical and scientific treatments


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Healthcare Bioconvergence Market

What is the estimated value of the Global Healthcare Bioconvergence Market?

The Global Healthcare Bioconvergence Market was estimated to be valued at $121.7 Billion in 2022.

What is the growth rate of the Global Healthcare Bioconvergence Market?

The growth rate of the Global Healthcare Bioconvergence Market is 7.4%, with an estimated value of $215.2 Billion by 2030.

What is the forecasted size of the Global Healthcare Bioconvergence Market?

The Global Healthcare Bioconvergence Market is estimated to be worth $215.2 Billion by 2030.

Who are the key companies in the Global Healthcare Bioconvergence Market?

Key companies in the Global Healthcare Bioconvergence Market include BIOMX., SINGOTA SOLUTION, ANIMA BIOTECH INC., GINKGO BIOWORKS, SETPOINT MEDICAL CORPORATION, ZYMERGEN INC., GALVANI BIOELECTRONICS and THE BIO CONVERGENCE COMPANY.

Table of Contents

Chapter 1 Report Scope and Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information Or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Application
3.2.4 Region
3.3 Competitive Insights
3.4 Healthcare Bioconvergence Market Outlook, 2021
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Healthcare Bioconvergence Market Dynamics
4.2.1 Market Driver Analysis
4.2.2 Market Restraint Analysis
4.3 Healthcare Bioconvergence: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Competitive Rivalry
4.3.1.2 Threat Of Substitutes
4.3.1.3 Threat Of Entrants
4.3.1.4 Bargaining Power Of Buyers
4.3.1.5 Bargaining Power Of Suppliers
4.3.2 Pestel Analysis
4.3.2.1 Political & legal
4.3.2.2 Economic & social
4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Impact of COVID-19 on Healthcare Bioconvergence Market
Chapter 5 Healthcare Bioconvergence Market: Application Analysis
5.1 Healthcare Bioconvergence Application Market Share Analysis, 2021 & 2030
5.2 Healthcare Bioconvergence Application Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment
5.3.1 Drug Discovery
5.3.1.1 Drug Discovery Market, 2017 - 2030 (USD Million)
5.3.2 Nanorobotics For Drug Delivery
5.3.2.1 Nanorobotics For Drug Delivery Market, 2017 - 2030 (USD Million)
5.3.3 Regenerative Medicine
5.3.3.1 Regenerative Medicine Market, 2017 - 2030 (USD Million)
5.3.4 Diagnostic And Biological Sensors
5.3.4.1 Diagnostic And Biological Sensors Market, 2017 - 2030 (USD Million)
5.3.5 Bioelectronics
5.3.5.1 Bioelectronics Market, 2017 - 2030 (USD Million)
5.3.6 Engineered Living Materials
5.3.6.1 Engineered Living Materials Market, 2017 - 2030 (USD Million)
5.3.7 Optogenetics
5.3.7.1 Optogenetics Market, 2017 - 2030 (USD Million)
5.3.8 Precision Medicine
5.3.8.1 Precision medicine market, 2017 - 2030 (USD Million)
Chapter 6 Healthcare Bioconvergence Market: Regional Analysis
6.1 Healthcare Bioconvergence Regional Market Share Analysis, 2021 & 2030
6.2 Regional Market Snapshot
6.3 North America
6.3.1 North America Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.3.3 Canada
6.3.3.1 Canada Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4 Europe
6.4.1 Europe Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4.2 U.K.
6.4.2.1 U.K. Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4.3 Germany
6.4.3.1 Germany Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4.4 France
6.4.4.1 France Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4.5 Italy
6.4.5.1 Italy Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4.6 Spain
6.4.6.1 Spain Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.4.7 Russia
6.4.7.1 Russia Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5.2 Japan
6.5.2.1 Japan Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5.3 China
6.5.3.1 China Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5.4 India
6.5.4.1 India Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5.5 Australia
6.5.5.1 Australia Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5.6 South Korea
6.5.6.1 South Korea Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.5.7 Singapore
6.5.7.1 Singapore Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.6 Latin America
6.6.1 Latin America Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.6.3 Mexico
6.6.3.1 Mexico Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.6.4 Argentina
6.6.4.1 Argentina Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.6.5 Colombia
6.6.5.1 Colombia Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.7 Middle East And Africa (Mea)
6.7.1 Mea Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.7.3 Saudi Arabia
6.7.3.1 Saudi Arabia Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.7.4 Uae
6.7.4.1 Uae Healthcare Bioconvergence Market, 2017 - 2030 (USD Million)
6.7.5 Israel
6.7.5.1 Israel healthcare bioconvergence market, 2017 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Profiles
7.2.1 BIOMX.
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.2 Product benchmarking
7.2.1.3 Strategic initiatives
7.2.2 SINGOTA SOLUTION
7.2.2.1 Company overview
7.2.2.2 Product benchmarking
7.2.3 ANIMA BIOTECH INC.
7.2.3.1 Company overview
7.2.3.3 Product benchmarking
7.2.4 GINKGO BIOWORKS
7.2.4.1 Company overview
7.2.4.2 Product benchmarking
7.2.4.3 Strategic initiatives
7.2.5 SETPOINT MEDICAL CORPORATION
7.2.5.1 Company overview
7.2.5.2 Product benchmarking
7.2.5.3 Strategic initiatives
7.2.6 ZYMERGEN INC.
7.2.6.1 Company overview
7.2.6.2 Product benchmarking
7.2.6.3 Strategic initiatives
7.2.7 GALVANI BIOELECTRONICS
7.2.7.1 Company overview
7.2.7.2 Product benchmarking
7.2.8 BICO - THE BIO CONVERGENCE COMPANY
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives
Chapter 8 KOL Commentary
List of Tables
Table 1 List of secondary sources
Table 2 North America healthcare bioconvergence market estimates and forecasts, by country, 2017 - 2030 (USD Million)
Table 3 North America healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 4 U.S. healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 5 Canada healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 6 Europe healthcare bioconvergence market estimates and forecasts, by country, 2017 - 2030 (USD Million)
Table 7 Europe healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 8 U.K. healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 9 Germany healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 10 France healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 11 Italy healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 12 Spain healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 13 Russia healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 14 Asia Pacific healthcare bioconvergence market estimates and forecasts, by country, 2017 - 2030 (USD Million)
Table 15 Asia Pacific healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 16 Japan healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 17 China healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 18 India healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 19 Australia healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 20 South Korea healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 21 Singapore healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 22 Latin America healthcare bioconvergence market estimates and forecasts, by country, 2017 - 2030 (USD Million)
Table 23 Latin America healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 24 Brazil healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 25 Mexico healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 26 Argentina healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 27 Colombia healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 28 MEA healthcare bioconvergence market estimates and forecasts, by country, 2017 - 2030 (USD Million)
Table 29 MEA healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 30 South Africa healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 31 Saudi Arabia healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 32 UAE healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 33 Israel healthcare bioconvergence market estimates and forecasts, by application, 2017 - 2030 (USD Million)
List of Figures
FIG. 1 Healthcare bioconvergence market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Healthcare bioconvergence market outlook, 2021 (USD Million)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Healthcare bioconvergence application market share analysis, 2021 & 2030 (USD Million)
Fig. 15 Healthcare bioconvergence application market: Segment dashboard
Fig. 16 Drug discovery market, 2017 - 2030 (USD Million)
Fig. 17 Nanorobotics for drug delivery market, 2017 - 2030 (USD Million)
Fig. 18 Regenerative medicine market, 2017 - 2030 (USD Million)
Fig. 19 Diagnostic and biological sensors market, 2017 - 2030 (USD Million)
Fig. 20 Bioelectronics market, 2017 - 2030 (USD Million)
Fig. 21 Engineered living materials market, 2017 - 2030 (USD Million)
Fig. 22 Optogenetics market, 2017 - 2030 (USD Million)
Fig. 23 Precision medicine health market, 2017 - 2030 (USD Million)
Fig. 24 Healthcare bioconvergence regional market share analysis, 2021 & 2030 (USD Million)
Fig. 25 Regional market place: Key takeaways
Fig. 26 North America healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 27 U.S. healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 28 Canada healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 29 Europe healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 30 U.K. healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 31 Germany healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 32 France healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 33 Italy healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 34 Spain healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 35 Russia healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 36 Asia Pacific healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 37 Japan healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 38 China healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 39 India healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 40 Australia healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 41 South Korea healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 42 Singapore healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 43 Latin America healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 44 Brazil healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 45 Mexico healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 46 Argentina healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 47 Colombia healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 48 MEA healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 49 South Africa healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 50 Saudi Arabia healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 51 UAE healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 52 Israel healthcare bioconvergence market, 2017 - 2030 (USD Million)
Fig. 53 Strategy framework

Companies Mentioned

  • BIOMX.
  • SINGOTA SOLUTION
  • ANIMA BIOTECH INC.
  • GINKGO BIOWORKS
  • SETPOINT MEDICAL CORPORATION
  • ZYMERGEN INC.
  • GALVANI BIOELECTRONICS
  • BICO - THE BIO CONVERGENCE COMPANY

Methodology

Loading
LOADING...